Inventor · disambiguated record
Kristian Jensen
Also filed as: JENSEN KRISTIAN · JENSEN KRISTIAN BANG · JENSEN KRISTIAN HOBOLT
18 granted patents·17 pending applications·111 citations·filing 2003–2024
93Inventor score
Files withHOFFMANN LA ROCHE9SANOFI SA9PIERIS PHARMACEUTICALS GMBH6JENSEN KRISTIAN2AGILENT TECHNOLOGIES INC1
Top patents by PatentIndex Score
35 records- 0195US9884898B2Proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2017·Granted Feb 6, 2018·17 cites·20 claims
- 0294US9260492B2Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)MATSCHINER GABRIELE·Filed 2011·Granted Feb 16, 2016·27 cites·18 claims
- 0390US9051382B2Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding suchTRENTMANN STEFAN·Filed 2011·Granted Jun 9, 2015·26 cites·13 claims
- 0489US10046027B2Muteins of tear lipocalin and methods for obtaining the samePIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Aug 14, 2018·8 cites·14 claims
- 0588US8313924B2Muteins of tear lipocalin and methods for obtaining the sameJENSEN KRISTIAN·Filed 2007·Granted Nov 20, 2012·14 cites·44 claims
- 0687US10526384B2Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereofPIERIS PHARMACEUTICALS GMBH·Filed 2013·Granted Jan 7, 2020·5 cites·16 claims
- 0781US9221887B2Muteins of tear lipocalin and methods for obtaining the sameJENSEN KRISTIAN·Filed 2012·Granted Dec 29, 2015·5 cites·14 claims
- 0881US2023279155A1Dual targetingHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0979US2024101657A1Antibody that binds to vegf and il-1beta and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1078US10329334B2Proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2017·Granted Jun 25, 2019·1 cites·13 claims
- 1178US10118952B2Proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2017·Granted Nov 6, 2018·1 cites·15 claims
- 1278US10072056B2Proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2017·Granted Sep 11, 2018·1 cites·18 claims
- 1378US10065998B2Proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2017·Granted Sep 4, 2018·1 cites·18 claims
- 1475US10947284B2Fusion moleculesPIERIS PHARMACEUTICALS GMBH·Filed 2019·Granted Mar 16, 2021·1 cites·22 claims
- 1575US10316071B2Fusion moleculesSANOFI SA·Filed 2016·Granted Jun 11, 2019·2 cites·15 claims
- 1675US9944719B2Dual targetingDUTALYS GMBH·Filed 2013·Granted Apr 17, 2018·2 cites·4 claims
- 1773US11866490B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2021·Granted Jan 9, 2024·0 cites·36 claims
- 1871US11130804B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·0 cites·28 claims
- 1968US2021079119A1Dual targetingHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2066US2025163139A1Antibody that binds to vegf-a and il6 and methods of useHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2166US2018371038A1Novel proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2018·Application pending·0 cites
- 2266US2018371037A1Novel proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2018·Application pending·0 cites
- 2366US2018346532A1Novel proteins specific for pyoverdine and pyochelinSANOFI SA·Filed 2018·Application pending·0 cites
- 2461US2018094078A1Dual targetingHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2560US2020148733A1Novel interleukin-17a-specific and interleukin-23-specific binding polypeptides and uses thereofPIERIS PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 2659US2019015477A1Muteins of tear lipocalin and methods for obtaining the samePIERIS PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 2758US2023105324A1Antibody that binds to vegf and pdgf-b and methods of useHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2857US2020292535A1Method for evaluation of target in histological sampleAGILENT TECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2952US2017369542A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 3051US2014255405A1Removal of Monomeric TargetsDUTALYS·Filed 2012·Application pending·0 cites
- 3151US2017253672A1Removal of monomeric targetsHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 3249US9376358B2System and method for removal of heavy metal ions from a rich hydrate inhibitor streamFJORDS PROC AS·Filed 2013·Granted Jun 28, 2016·0 cites·10 claims
- 3347US10648970B2Method for evaluation of target in histological sampleDAKO DENMARK AS·Filed 2012·Granted May 12, 2020·0 cites·20 claims
- 3446US2015291675A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS AG·Filed 2015·Application pending·0 cites
- 3542US2004225969A1Hand-portable electronic device with symbolic calendar applicationNOKIA CORP·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristian Jensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →